About DENTSPLY SIRONA (NASDAQ:XRAY)
DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies. The dental industry encompasses the diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. Its principal dental product categories are dental consumable products, dental laboratory products, dental specialty products and dental equipment. Additionally, its consumable medical device products are used for urological and surgical applications. These products are produced by the Company in the United States and internationally and are distributed throughout the world under various brand names, including ANKYLOS, AQUASIL ULTRA, ARTICADENT, ATLANTIS, CALIBRA, CAULK, CAVITRON, CELTRA, DELTON, DENTSPLY, DETREY and DYRACT.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Equipment, Supplies & Distribution
- Sub-Industry: Health Care Supplies
- Symbol: NASDAQ:XRAY
- CUSIP: 24903010
- Web: www.dentsplysirona.com
- Market Cap: $14.19 billion
- Outstanding Shares: 229,501,000
- 50 Day Moving Avg: $58.51
- 200 Day Moving Avg: $61.00
- 52 Week Range: $52.53 - $65.68
Sales & Book Value:
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 20.89
- P/E Growth: 3.22
- Annual Revenue: $3.84 billion
- Price / Sales: 3.69
- Book Value: $31.67 per share
- Price / Book: 1.95
- Annual Dividend: $0.35
- Dividend Yield: 0.6%
- EBITDA: $823.8 million
- Net Margins: -20.57%
- Return on Equity: 7.24%
- Return on Assets: 5.02%
- Debt-to-Equity Ratio: 0.22%
- Current Ratio: 2.34%
- Quick Ratio: 1.55%
- Average Volume: 2.05 million shs.
- Beta: 1.28
- Short Ratio: 4.53
Frequently Asked Questions for DENTSPLY SIRONA (NASDAQ:XRAY)
What is DENTSPLY SIRONA's stock symbol?
DENTSPLY SIRONA trades on the NASDAQ under the ticker symbol "XRAY."
How often does DENTSPLY SIRONA pay dividends? What is the dividend yield for DENTSPLY SIRONA?
DENTSPLY SIRONA declared a quarterly dividend on Wednesday, June 28th. Investors of record on Friday, September 29th will be paid a dividend of $0.0875 per share on Friday, October 13th. This represents a $0.35 annualized dividend and a yield of 0.57%. The ex-dividend date is Thursday, September 28th. View DENTSPLY SIRONA's Dividend History.
How were DENTSPLY SIRONA's earnings last quarter?
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) posted its quarterly earnings results on Wednesday, August, 9th. The company reported $0.65 earnings per share for the quarter, hitting the Thomson Reuters' consensus estimate of $0.65. The business had revenue of $992.70 million for the quarter, compared to analyst estimates of $1 billion. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The company's revenue was down 2.9% on a year-over-year basis. During the same quarter last year, the business earned $0.76 earnings per share. View DENTSPLY SIRONA's Earnings History.
When will DENTSPLY SIRONA make its next earnings announcement?
What guidance has DENTSPLY SIRONA issued on next quarter's earnings?
DENTSPLY SIRONA issued an update on its FY17 earnings guidance on Monday, October, 2nd. The company provided earnings per share (EPS) guidance of $2.65-2.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.68.
Where is DENTSPLY SIRONA's stock going? Where will DENTSPLY SIRONA's stock price be in 2017?
9 equities research analysts have issued 1 year price targets for DENTSPLY SIRONA's stock. Their forecasts range from $55.00 to $75.00. On average, they anticipate DENTSPLY SIRONA's share price to reach $65.63 in the next twelve months. View Analyst Ratings for DENTSPLY SIRONA.
Who are some of DENTSPLY SIRONA's key competitors?
Some companies that are related to DENTSPLY SIRONA include Zimmer Biomet Holdings (ZBH), C.R. Bard (BCR), Align Technology (ALGN), Steris Plc (STE), West Pharmaceutical Services (WST), Bio-Rad Laboratories (BIO), Hill-Rom Holdings (HRC), VWR Corporation (VWR), Integra Lifesciences Holdings Corp (IART), DexCom (DXCM), ICU Medical (ICUI), LivaNova PLC (LIVN), Neogen Corporation (NEOG), NuVasive (NUVA), Nevro Corp. (NVRO), Haemonetics Corporation (HAE), Halyard Health (HYH) and Inogen (INGN).
Who are DENTSPLY SIRONA's key executives?
DENTSPLY SIRONA's management team includes the folowing people:
- Robert J. Size, Interim President and Chief Operating Officer - Technologies
- Mark Alan Thierer, Interim Chief Executive Officer
- Ulrich Michel, Chief Financial Officer, Executive Vice President
- Maureen J. MacInnis, Chief Human Resource Officer, Senior Vice President
- Rainer Berthan, Executive Vice President, Manufacturing and Supply Chain
- Jonathan I. Friedman, Senior Vice President, General Counsel, Secretary
- Eric K. Brandt, Non-Executive Independent Chairman of the Board
- Thomas Jetter Ph.D., Lead Independent Director
- David K. Beecken M.D., Director
- Arthur D. Kowaloff, Director
Who owns DENTSPLY SIRONA stock?
DENTSPLY SIRONA's stock is owned by many different of institutional and retail investors. Top institutional investors include Independent Franchise Partners LLP (0.70%), Douglas Lane & Associates LLC (0.24%), Nationwide Fund Advisors (0.19%), Mountain Pacific Investment Advisers Inc. ID (0.17%), Harvey Investment Co. LLC (0.09%) and Bartlett & Co. LLC (0.05%). Company insiders that own DENTSPLY SIRONA stock include Arthur D Kowaloff, Bret W Wise, Christopher T Clark, Deborah Rasin, Eric Brandt, Harry M Jansen Kraemer Jr, James G Mosch, Maureen J Macinnis, Michael C Alfano, Rainer Berthan and Ulrich Michel. View Institutional Ownership Trends for DENTSPLY SIRONA.
Who sold DENTSPLY SIRONA stock? Who is selling DENTSPLY SIRONA stock?
DENTSPLY SIRONA's stock was sold by a variety of institutional investors in the last quarter, including State Treasurer State of Michigan, Bartlett & Co. LLC, Farmers & Merchants Investments Inc., Quantitative Systematic Strategies LLC and Mutual of America Capital Management LLC. Company insiders that have sold DENTSPLY SIRONA stock in the last year include Arthur D Kowaloff, Bret W Wise, Christopher T Clark, Eric Brandt, James G Mosch and Ulrich Michel. View Insider Buying and Selling for DENTSPLY SIRONA.
Who bought DENTSPLY SIRONA stock? Who is buying DENTSPLY SIRONA stock?
DENTSPLY SIRONA's stock was acquired by a variety of institutional investors in the last quarter, including Independent Franchise Partners LLP, APG Asset Management N.V., Douglas Lane & Associates LLC, Nationwide Fund Advisors, Carnick & Kubik Group LLC, Verde Servicos Internacionais S.A., Assenagon Asset Management S.A. and Mountain Pacific Investment Advisers Inc. ID. View Insider Buying and Selling for DENTSPLY SIRONA.
How do I buy DENTSPLY SIRONA stock?
Shares of DENTSPLY SIRONA can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is DENTSPLY SIRONA's stock price today?
MarketBeat Community Rating for DENTSPLY SIRONA (NASDAQ XRAY)MarketBeat's community ratings are surveys of what our community members think about DENTSPLY SIRONA and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of DENTSPLY SIRONA stock can currently be purchased for approximately $61.82.
Consensus Ratings for DENTSPLY SIRONA (NASDAQ:XRAY) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Sell Rating, 2 Hold Ratings, 6 Buy Ratings|
|Consensus Rating:||Buy (Score: 2.56)|
|Consensus Price Target: ||$65.63 (6.15% upside)|Consensus Price Target History for DENTSPLY SIRONA (NASDAQ:XRAY)
Analysts' Ratings History for DENTSPLY SIRONA (NASDAQ:XRAY)
(Data available from 10/24/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|10/19/2017||Robert W. Baird||Set Price Target||Buy||$63.00||N/A|
|10/19/2017||Stifel Nicolaus||Reiterated Rating||Buy||N/A|
|10/6/2017||Morgan Stanley||Reiterated Rating||Overweight||$67.00 -> $69.00||N/A|
|10/5/2017||Cleveland Research||Downgrade||Buy -> Neutral||N/A|
|10/3/2017||HC Wainwright||Reiterated Rating||Buy||$68.00||Low|
|8/23/2017||Jefferies Group LLC||Lower Price Target||Buy||$72.00 -> $66.00||High|
|7/13/2017||Credit Suisse Group||Reiterated Rating||Outperform||$67.00 -> $75.00||Low|
|5/23/2017||Goldman Sachs Group, Inc. (The)||Downgrade||Neutral -> Sell||$60.00 -> $55.00||Medium|
|2/21/2017||Barrington Research||Downgrade||Outperform -> Market Perform||N/A|
|9/22/2016||J P Morgan Chase & Co||Initiated Coverage||Neutral||$65.00||N/A|
|9/12/2016||Bank of America Corporation||Initiated Coverage||Buy||$70.00||N/A|
|6/27/2016||Piper Jaffray Companies||Reiterated Rating||Buy||N/A|
|3/14/2016||William Blair||Downgrade||Outperform -> Market Perform||N/A|
|10/29/2015||Keefe, Bruyette & Woods||Boost Price Target||Outperform||$61.00 -> $64.00||N/A|
Earnings History for DENTSPLY SIRONA (NASDAQ:XRAY)Earnings History by Quarter for DENTSPLY SIRONA (NASDAQ XRAY)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/9/2017||Q2 2017||$0.65||$0.65||$1.00 billion||$992.70 million||View||Listen|
|5/9/2017||Q1 17||$0.50||$0.49||$916.55 million||$900.50 million||View||Listen|
|2/17/2017||Q4 2016||$0.65||$0.67||$1.02 billion||$996.50 million||View||Listen|
|11/4/2016||Q316||$0.63||$0.66||$967.68 million||$954.20 million||View||Listen|
|8/5/2016||Q216||$0.70||$0.76||$1.03 billion||$1.02 billion||View||Listen|
|5/6/2016||Q1||$0.63||$0.69||$741.80 million||$772.60 million||View||N/A|
|2/12/2016||Q415||$0.65||$0.65||$687.35 million||$671.10 million||View||Listen|
|10/28/2015||Q3||$0.63||$0.66||$667.00 million||$648.90 million||View||Listen|
|7/30/2015||Q215||$0.68||$0.73||$715.49 million||$698.00 million||View||Listen|
|5/6/2015||Q115||$0.57||$0.59||$690.16 million||$656.30 million||View||Listen|
|2/18/2015||Q414||$0.61||$0.60||$751.04 million||$719.00 million||View||Listen|
|10/29/2014||Q314||$0.60||$0.62||$725.83 million||$708.00 million||View||Listen|
|7/31/2014||Q2||$0.68||$0.69||$782.86 million||$765.20 million||View||Listen|
|5/6/2014||Q1||$0.56||$0.59||$747.27 million||$730.10 million||View||Listen|
|2/18/2014||Q4||$0.61||$0.61||$767.89 million||$753.70 million||View||Listen|
|10/29/2013||Q313||$0.56||$0.57||$716.13 million||$704.00 million||View||Listen|
|8/1/2013||Q2 2013||$0.65||$0.66||$782.73 million||$761.00 million||View||Listen|
|5/9/2013||Q1 2013||$0.56||$0.52||$732.87 million||$732.10 million||View||Listen|
|2/20/2013||Q4 2012||$0.56||$0.56||$748.56 million||$753.30 million||View||Listen|
Earnings Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)
2017 EPS Consensus Estimate: $2.79
2018 EPS Consensus Estimate: $2.93
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Current Dividend Information for DENTSPLY SIRONA (NASDAQ:XRAY)
|Most Recent Dividend:||10/13/2017|
|Payout Ratio:||-10.09% (Trailing 12 Months of Earnings) |
13.06% (Based on This Year's Estimates)
11.82% (Based on Next Year's Estimates)
Dividend History by Quarter for DENTSPLY SIRONA (NASDAQ XRAY)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for DENTSPLY SIRONA (NASDAQ:XRAY)
Insider Ownership Percentage: 1.99%Insider Trades by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)
Institutional Ownership Percentage: 93.87%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|4/24/2017||James G Mosch||CEO||Sell||50,600||$63.49||$3,212,594.00|| |
|4/7/2017||Christopher T Clark||CEO||Sell||89,700||$62.67||$5,621,499.00|| |
|3/9/2017||Ulrich Michel||Insider||Sell||24,000||$62.84||$1,508,160.00|| |
|3/2/2017||Eric Brandt||Director||Sell||2,941||$64.35||$189,253.35|| |
|3/1/2017||Bret W Wise||Insider||Sell||146,900||$64.17||$9,426,573.00|| |
|2/17/2017||Arthur D Kowaloff||Director||Sell||27,213||$62.00||$1,687,206.00|| |
|2/17/2017||Christopher T Clark||CEO||Sell||64,500||$60.70||$3,915,150.00|| |
|11/17/2016||James G Mosch||CEO||Sell||30,400||$60.93||$1,852,272.00|| |
|9/6/2016||Rainer Berthan||VP||Sell||5,000||$61.12||$305,600.00|| |
|8/25/2016||Maureen J Macinnis||SVP||Sell||45,100||$60.55||$2,730,805.00|| |
|8/23/2016||Maureen J Macinnis||SVP||Sell||17,650||$60.61||$1,069,766.50|| |
|6/2/2016||Rainer Berthan||VP||Sell||6,464||$62.56||$404,387.84|| |
|5/26/2016||Michael C Alfano||Director||Sell||3,000||$61.58||$184,740.00|| |
|5/16/2016||Harry M Jansen Kraemer Jr||Director||Sell||27,213||$62.17||$1,691,832.21|| |
|3/29/2016||Arthur D Kowaloff||Director||Sell||13,006||$62.00||$806,372.00|| |
|11/18/2015||Deborah Rasin||VP||Sell||4,500||$60.56||$272,520.00|| |
|11/4/2015||Michael C Alfano||Director||Sell||2,500||$62.15||$155,375.00|| |
|11/3/2015||Deborah Rasin||VP||Sell||14,000||$61.70||$863,800.00|| |
|3/30/2015||Christopher T Clark||Insider||Sell||85,566||$51.18||$4,379,267.88|| |
|2/20/2015||Deborah Rasin||VP||Sell||11,000||$52.47||$577,170.00|| |
|2/20/2015||Michael J Coleman||Director||Sell||18,000||$52.47||$944,460.00|| |
|1/9/2015||Robert J Size||VP||Sell||9,200||$52.97||$487,324.00|| |
|12/8/2014||Leslie A Jones||Director||Sell||18,000||$55.45||$998,100.00|| |
|12/4/2014||Albert Sterkenburg||VP||Sell||23,200||$55.62||$1,290,384.00|| |
|11/7/2014||Michael C Alfano||Director||Sell||20,000||$51.23||$1,024,600.00|| |
|11/5/2014||James G Mosch||VP||Sell||55,042||$51.25||$2,820,902.50|| |
|11/4/2014||Francis J Lunger||Director||Sell||9,160||$50.90||$466,244.00|| |
|10/31/2014||Albert Sterkenburg||VP||Sell||2,000||$50.51||$101,020.00|| |
|10/31/2014||John C Miles II||Director||Sell||20,000||$50.65||$1,013,000.00|| |
|8/25/2014||Leslie A Jones||Director||Sell||2,000||$48.30||$96,600.00|| |
|7/3/2014||Christopher T Clark||Insider||Sell||27,521||$47.74||$1,313,852.54|| |
|5/30/2014||Michael C Alfano||Director||Sell||2,764||$47.25||$130,599.00|| |
|5/19/2014||Leslie Jones||Director||Sell||2,000||$46.49||$92,980.00|| |
|5/12/2014||Robert Size||VP||Sell||5,049||$46.29||$233,718.21|| |
|12/11/2013||Bret Wise||Chairman||Sell||90,000||$48.50||$4,365,000.00|| |
|12/9/2013||Francis Lunger||Director||Sell||18,000||$47.66||$857,880.00|| |
|12/6/2013||Bret Wise||Chairman||Sell||24,323||$47.66||$1,159,234.18|| |
|12/2/2013||Bret Wise||Chairman||Sell||66,761||$47.53||$3,173,150.33|| |
|12/2/2013||William Hecht||Director||Sell||18,000||$47.49||$854,820.00|| |
|11/8/2013||Leslie Jones||Director||Sell||2,000||$47.68||$95,360.00|| |
|10/21/2013||Robert J Size||VP||Sell||14,262||$46.00||$656,052.00|| |
|9/11/2013||Robert Size||VP||Sell||8,200||$45.00||$369,000.00|| |
|9/10/2013||James G Mosch||VP||Sell||41,836||$43.95||$1,838,692.20|| |
|7/31/2013||Christopher T Clark||Insider||Sell||20,918||$43.00||$899,474.00|| |
|7/31/2013||Eric Brandt||Director||Sell||18,000||$43.00||$774,000.00|| |
|7/9/2013||Christopher T Clark||Insider||Sell||20,918||$42.00||$878,556.00|| |
|6/3/2013||Leslie A Jones||Director||Sell||2,840||$41.76||$118,598.40|| |
|3/12/2013||Paula H Cholmondeley||Director||Sell||9,000||$42.70||$384,300.00|| |
|12/21/2012||Bret W Wise||Chairman||Sell||4,349||$40.50||$176,134.50|| |
Headline Trends for DENTSPLY SIRONA (NASDAQ:XRAY)
Latest Headlines for DENTSPLY SIRONA (NASDAQ:XRAY)
Loading headlines, please wait.
DENTSPLY SIRONA (XRAY) Chart for Tuesday, October, 24, 2017